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The major histocompatibility complex (MHC) 1 is a  cluster of closely linked genes 
that control cellular interactions in the immune system. Class ! MHC genes encode 
for 40-45,000-dahon  cell membrane glycoproteins that noncovalently associate with 
beta-2 microglobulin (1). While the function of many of these class I molecules is not 
understood,  some of them play a  role in  determining the specificity of cytotoxic T 
lymphocytes (CTL)  (2, 3). 
The  number of class I  MHC  genes  in  the  mouse  genome,  as estimated  by gene 
cloning,  is  ,--40  (4).  Although  some of these  hybridizing  DNA  fragments could  be 
pseudogenes  (5, 6), these data suggest that several other genes besides H-2K,  D,  and 
L  play  a  role  in  H-2  restriction  of T  cell  specificity.  To  identify  the  function  of 
individual H-2 genes, it is necessary to isolate the gene and study the function of its 
product. Recently, such technology has allowed for the isolation and transfer of such 
genes into mouse C3H L cells (7, 8). 
We have recently demonstrated that inoculation of vesicular stomatitis virus (VSV) 
into  BALB/c  animals  results  in  the  generation  of CTL that  are  restricted  by the 
H-2L a  gene  (9).  This evidence was obtained  using two approaches;  analysis of the 
response in H-2 recombinant and H-2D-region mutant strains, and blocking of lytic 
activity by precoating target cells with H-2-specific antisera and monoclones. 
More  recently,  the  H-2D  region  of H-2 a  has  been  shown  to  control  additional 
antigenic molecules, namely, L2  d and L2q, besides H-2D, L, M, and R  (10,  11). This 
raises the possibility that  these or other presently unknown  H-2 products could be 
responsible  for  restriction  of anti-VSV  CTL  activity.  In  this  respect,  serological 
reagents may not define the antigens since they could react with other molecules that 
share allodeterminants.  Therefore, to definitively establish the role of H-2L a  as the 
restricting element for anti-VSV CTL, we used the method of DNA-mediated gene 
transfer (7).  This technique  permitted the transfer of a  single BALB/c gene, H-2L a, 
into L  (H-2  k) cells. While VSV-infected normal L cells are not lysed by BALB/c anti- 
VSV CTL, L cells transformed with the H-2L a gene express its product and are lysed 
by anti-VSV CTL. Therefore, by using this technology we are able to unequivocally 
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demonstrate that a  single H-2 gene, H-2L d, functions as a  restricting element for anti- 
VSV  CTL. 
Materials  and  Methods 
Mice.  Mice  were  obtained  from  our  colony  at  the  University of Texas  Health  Science 
Center. 
Virus.  VSV of the Indiana  serotype was prepared  by passage of the virus stock in the rat 
cell line R(B77).  The source and culture conditions of R(B77)  have been previously described 
(12).  VSV was titered by a  plaque assay using R(B77)  monolayers. 
Cells.  P815 tumor cells (a DBA/2 mastocytoma)  were maintained by twice-weekly passage 
in  vitro  in  RPMI  medium  supplemented  with  10%  fetal  calf serum  (FCS)  and  antibiotics. 
Alloreactive cytotoxic cells were induced following previouslyspublished procedures  (9).  Spleen 
cells obtained  from mice immunized  6  d  previously with  10  plaque-forming units  (PFU)  of 
VSV were restimulated in vitro with VSV-infected stimulator cells to generate secondary anti- 
VSV CTL.  The procedure  has  been  described in detail elsewhere  (13).  Secondary  anti-VSV 
CTL were used in all experiments described in this report. 
Cells were transfected with the H-2L a gene as previously described (7).  Briefly, two cell lines 
derived from transformation of C3H mouse L cells were used. Ltk  ÷ cells (designated tk +) were 
obtained by transfection of thymidine kinase  (tk)-negative (Ltk-)  cells with the cloned herpes 
viral tk gene, and 8-5 cells were derived by the co-transformation of Ltk- cells with the herpes 
viral tk gene and  DNA from the genomic clone 27.5  containing the BALB/c H-2L a gene  (7, 
14).  Transformants  were selected and  cloned  in alpha-minimal  essential  medium  containing 
10%  FCS and  hypoxanthine,  aminopterin,  and  thymidine  (HAT medium)  as  described  (7). 
Both 8-5 and tk  ÷ cells were maintained in HAT medium as adherent cell lines in 75-cm  2 tissue 
culture  flasks.  Before use as  targets,  cells were removed from  the plastic by incubation  with 
0.02% trypsin at 37°C for 3-5 min. Trypsin activity was terminated by the addition of medium 
containing  10% FCS. 
Assay for CTL Activity.  CTL activity was measured using a standard chromium release assay 
(9).  Various  numbers  of normal  or immune  lymphocytes were added  to a  constant  number 
(104) of target cells in microtiter plates. After 4 h of incubation at 37°C, the cells were pelleted 
by centrifugation and the supernatant  was measured for radioactivity. Cold target competition 
analysis was performed following previously published  procedures  (9)  using 2.5  ×  10  ~ effector 
cells and 2.5 ×  10  a target cells together with various numbers of inhibitor cells. 
When  hybridoma  products  were  tested  for  their  ability  to  inhibit  CTL  activity,  labeled 
targets  were  incubated  with  the indicated  quantities  of antibodies  for 45  min  at  37°C.  The 
effector cells were then added  and  the mixtures incubated  and  processed as described  for the 
CTL assay. 
Net release of isotope was calculated by substracting the percent 5~Cr release from target cells 
cultured in media alone from the percent 51Cr release from target cells cultured in the presence 
of effector cells. The standard  error from three replicates in each group was <5%. Spontaneous 
release ranged from 8 to 34%. 
Maximum release of isotope  (water lysis)  from P815 cells was generally 85%, whereas from 
L cell targets, the release was usually  10-15% lower. The calculation of percent isotope release 
does not take this factor into account. 
Monoclonal Antibodies.  Monoclonal  antibodies  were  the  generous  gift  of Dr.  Ted  Hansen, 
Merck Institute  for Therapeutic  Research,  Rahway,  N  J, and  have been  described previously 
d  d  (9,  15). Briefly, 30-5-7 is directed against H-2L  (2.65) and 34-2-12 is specific for H-2D  but not 
d  d  H-2L  or H-2R  (H-2.4).  Both are IgG2, antibodies.  UPC10 myeloma (IgG2a)  protein  (Litton 
Bionetics, Kensington,  MD) at a  concentration of 1 mg/ml was used as a  control. 
Fluorescence-activated Cell Sorter (FACS)  Analysis.  Cells were  analyzed  for  fluorescence and 
light  scatter  on  a  FACS  III  (B-D FACS  Systems  Becton,  Dickinson  & Co.,  Sunnyvale,  CA) 
instrument  at  a  fluorescent  gain  of 4.  Cells were  prepared  for  analysis  by  incubation  with 
monoclonal  antibodies  or  myeloma  protein  (UPC10)  followed by washing  and  exposure  to 
fluoresceinated (F)- F(ab')z anti-mouse Ig (N. L. Cappel Laboratories, Cochranville, PA) in the 
presence of medium  containing heat-inactivated  normal  rabbit  serum  to prevent nonspecific 
binding to Fc receptors.  10,000  cells were analyzed. FORMAN  ET  AL.  1263 
Results 
Recognition of H-2L a in  Transformed H-2L  Cells.  tk--  C3H  (H-2k)-derived L  cells 
(Ltk-) were transformed with either the herpes simplex virus (HSV)  tk gene or the tk 
gene together with the BALB/c  DNA  genomic clone 27.5,  which encodes for H-2L a 
L  cells referred to as 8-5 represent a  cloned tk  + 27.5 transformant selected in medium 
containing HAT  that expresses H-2L  a  (7). Moreover, two-dimensional gel analysis of 
TABLE  I 
Sensitivity of 8-5 Cells to Lysis by Alloreactive CTL 
Effector cells  Experiment  P815 
Target cells* 
8-5  tk  + 
1005  50  10  100  50  10  100  50  10 
BALB/c anti-Bl0.BR  1  6§  5  0  59  58  32  28  26  15 
2  7  6  3  63  64  59  44  38  26 
B10.BR anti-BALB/c  1  62  59  25  3i  24  9  4  5  1 
2  69  71  58  5i  45  24  4  4  2 
* Target cells were uninfected in experiment 1 and infected with VSV in experiment 2. 
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FIG.  2.  Expression of H-2L  d determined by flow microfluorometry. P815  (top panel), 8-5  (middle 
panel), and  tk  +  (bottom panel)  cells  were exposed to monoclonal antibody  (30-5-7)  that  detects 
d  specificity 2.65  (H-2L) followed by F-F(ab')2 anti-Ig.  10,000 cells were then analyzed. For control, 
an aliquot ofcells was incubated with UPCI0 myeloma protein rather than 30-5-7. Dead cells were 
excluded from analysis. Relative increasing intensity of fluorescence on the X  axis is plotted vs. the 
number of cells/channel on the Y axis. 
the product expressed by this cell line shows no differences with H-2L  d obtained from 
BALB/c splenocytes  (7).  To  determine  if CTL  recognize the  H-2L  d antigen on  the 
transfected  cells, we  generated  anti-H-2  a  and  anti-H-2L  d  specific  CTL  and  tested 
them against 8-5 target cells. 
The  data  presented  in  Table  I  demonstrated  that  B10.BR  (H-2 k)  anti-BALB/c 
(H-2 a) effector cells display a lytic effect against P815 (H-2K a, H-2D "e, H-2L d) as well 
as 8-5 (H-2 k, H-2L a)  target cells, whereas cells transfected with the tk gene only (tk  + 
cells) are not killed. Further, the same target cells infected with VSV before exposure 
to anti-H-2  d CTL  show  the same pattern of lysis. BALB/c anti-B 10.BR  (anti-H-2  k) 
CTL  display lysis against 8-5  and  tk  ÷ but  not  P815  cells, as expected, although  the 
extent  of lysis of the  tk  +  cells was  usually  less  than  that  observed  against  the  8.5 
targets. 
The  above  effector  cells  are  potentially  directed  against  several  H-2 d  encoded FORMAN ET  AL.  1265 
B~ 
7~ 
6~ 
50 
4~ 
3~ 
2~ 
P815 
tm 
7~ 
5~ 
4~ 
2~ 
8.5 
/ 
/ 
/ 
J 
--t  ~  m  -  .  , 
s  1~  ~s  zz 
s  im  13  zs 
uL  ANT I BODY 
FIo. 3.  Ability of monoclonal antibodies to inhibit lysis by anti-H-2L  d CTL. P815 (left panel) or 
8-5 (right panel)  target cells were exposed to dm2 anti-BALB/c effector cells in the presence of 
myeloma protein (control) (×), anti-H-2L  a (monoclone 30-5-7) (O), or anti-H-2D  a (monoclone 34- 
2-12) (0). Net release of isotope in the absence of antibody against P815 target cells was 41% and 
against 8.5 cells was 17%. Percent inhibition = [ 1 -  (percent net release in the presence of antibody)/ 
(percent net release in the absence of antibody)]  X 100. 
alloantigens. Therefore, to determine whether anti-H-2L  d CTL  could also recognize 
target  antigens  on  the  8-5  transfectants,  we  generated  BALB/c-H-2  am2  (H-2 '~'~, 
abbreviated dm2)  anti-BALB/c CTL.  We and others  (9,  16)  have previously shown 
that these effector cells are directed against H-2L  d but not H-2D  d. The data in Fig. 1 
demonstrate that these effector cells are able to lyse P815 and 8-5 target cells but not 
the  tk  +  targets.  The  reason  for  the  higher  degree of isotope release  from  the  P815 
targets relative to 8-5 cells in the presence of anti-H-2L CTL is not known. However, 
consistent with this finding is the observation that the extent of isotope release due to 
osmotic shock is greater from P815 than 8-5 cells (see Materials and Methods for data 
on  H20  lysis).  In  any  event,  it  is  not  due  to  the  density of H-2L  a,  since  8-5  cells 
express  a  greater  amount  of this  antigen  than  P815  cells,  as  determined  by  flow 
cytometry (Fig. 2). 
To  further  establish  that  the  alloantigen  recognized  is  expressed  on  the  H-2L  a 
molecule, monoclones  directed against either H-2D  a or H-2L  a were  tested for their 
ability to  block  lysis by  effector  cells.  In  agreement  with  our  previous  study  (9), 
addition of anti-H-2L  d to both 8-5 and P815  target cells inhibited lysis by the dm2 
anti-BALB/c effector cells, whereas anti-H-2D  d had no  inhibitory effect  (Fig. 3, left 
panel).  Similar results were  noted when  8-5  targets were  used  (Fig. 3,  right  panel). 
Therefore,  these data demonstrate  that  H-2L  d,  as defined by alloreactive CTL  and 
monoclonal antibodies, is expressed on 8-5 target cells, and confirm the previous data 
ofOrn  et al. (17). 
Ability of H-2Ld-transformed L  Cells to Restrict  Anti-VSV CTL.  We previously dem- 
onstrated  (9)  that  the  H-2L a  gene  restricted  anti-VSV  CTL  in  BALB/c  animals. 
These data were obtained using H-2-recombinant and mutant  mouse strains as well 
as monoclonal  antibodies.  However, since these monoclones could potentially react 
with unknown  molecules controlled by a  gene(s)  in the D  region of H-2 d, we used 8-5 
target cells to unequivocally evaluate the role of Ho2L. 
BALB/c  animals  were  infected  with  VSV,  and  6  d  later  their  spleen cells were 1266  FUNCTION  OF tt-2L  d 
placed in culture with VSV-infected stimulator cells. After a  5-d culture period, the 
effector  cells were  tested  against VSV  infected or  uninfected target  ceils  for  their 
sensitivity to lysis. VSV-infected P815 cells were lysed by the CTL, whereas uninfected 
P815 targets were not (Fig. 4). 8-5 target ceils infected with VSV were also sensitive 
to lysis although to a  somewhat lesser extent than P815 targets. Uninfected 8-5 cells 
as well as infected and uninfected tk  + cells were not killed. Similar results were noted 
using DBA/2 (H-S)  effector cells (Fig. 5). 
Ability of Monoctonal Antibodies to Block Target Cell Lysis.  To establish that the target 
antigen on 8-5 cells was not an H-2k-controlled gene product, we used two anti-H-2  d 
monoclones to block lytic activity. Monoclones 30-5-7 and 34-2-12 react with H-2L  a 
and  H-2D  a,  respectively  (9,  15).  The  dat  presented  in  Fig.  6  demonstrate  that 
BALB/c  anti-VSV  CTL  are  completely  inhibited from  killing VSV-infected  8-5 
target cells in the presence of the anti-H-2L  a monoclone. As expected, the anti-H-2D  d 
monoclone had  no blocking effect.  Therefore,  the  fact  that  an  anti-H-2L  a  specific 
antibody blocks lysis indicates that H-2  k antigens do not account for anti-VSV CTL 
restriction. 
Role  of MHC  Genes Other Than  H-2L a  in  Restricting  Anti-VSV  CTL  in  BALB/c 
Animals.  The above data demonstrate that anti-VSV CTL generated in H-2  d animals 
recognize VSV in the context of H-2L a. However, they do not exclude the possibility 
that other gene products in addition to H-2L  a also restrict these effector cells. If this 
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were the case, then anti-VSV CTL generated in BALB/c animals and tested against 
P815-VSV  target  cells  in  the  presence  of 8-5  unlabeled  inhibitors  should  be only 
partially blocked in their lytic activity. The results of three such experiments (Fig.  7) 
show that neither VSV-infected tk  ÷ nor uninfected P815, 8.5, or tk  + cells block CTL 
activity. On the other hand, most of the anti-VSV activity directed against infected 
P815  target cells is blocked by unlabeled  P815-VSV inhibitors.  Similar results were 
observed  using  8-5-VSV  cells  as  inhibitors,  although  the  level  of  blocking  was 
somewhat less than that of P815 cells in two of the three experiments. However, since 
8-5 cells are less sensitive to lysis by anti-H-2L  a CTL than P815 cells, this result is not 
unexpected  (18).  Taken  together,  these  data  demonstrate  that  the  H-2L a gene,  as 
defined  by  the  DNA  sequence  of clone  27.5  (14),  is  the  major  if not  exclusive 
component controlling recognition by anti-VSV CTL in H-2  a animals. 
Discussion 
Recent estimates of the number of class I  genes in the mouse MHC number ~40 
(4). The genes that have been delineated by gene cloning include H-2K, D, L, Q  a-2, 
and TL (19). Some of the genes in this complex could be pseudogenes (5, 6). All of the 
class I  genes from BALB/c mice have been identifed and used to transform L  cells, 
which permits the identification of all class 1-restricting elements. The results of our 1268  FUNCTION OF H-2L  a 
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FIG. 6.  Ability of monoclonal antibody to inhibit lysis  of 8-5-VSV cells by anti-VSV CTL. VSV- 
infected 8-5 target cells were exposed to BALB/c anti-VSV effector cells in the presence of myeloma 
protein  (control), (×), anti-H-2L  a (O), or anti H-2D  a (0) monoclones. Net release of isotope in the 
absence of antibody was 32%. Percent inhibition calculated as in Fig. 3. 
present study demonstrate that the BALB/c DNA clone 27.5, which encodes H-2L  d, 
is the major restricting element for anti-VSV CTL generated in H-2 a animals. 
We  previously demonstrated  (9),  using H-2-recombinant  and  mutant  strains  to- 
gether with monoclonal antibodies, that H-2L d is the restricting element for anti-VSV 
CTL  in BALB/c animals. However, more recent evidence indicates that in addition 
to  H-2D,  L,  M,  and  R,  additional D  region-controlled antigens can  be detected in 
H-2 a mice (10,  11). These include Lq and L2  a. Further, it is conceivable that other H- 
2D  a  region-controlled molecules will subsequently  be  discovered, especially as  new 
monoclonal reagents are derived. Since some monoclonals would be expected to react 
with similar determinants on several different H-2 molecules  , the use of monoclonal 
antibodies to block CTL recognition does not definitively identify the gene responsible 
for restricting activity. Therefore, to unequivocally demonstrate that the H-2L a gene 
is responsible for restricting anti-VSV CTL, we used the technique of DNA-mediated 
gene transfer. The cells used for gene transfer were mouse C3H  L  (H-2 k) cells. These 
cells express H-2 k antigens and are recognized by anti-H-2  k alloreactive CTL.  How- 
ever,  infection  of these  cells with  VSV  does  not  render  them  sensitive to  lysis by 
BALB/c  (H-2 a)  anti-VSV effector cells. This demonstrates that  the H-2 k  haplotype 
does not control cross-reactive determinants that can be recognized by H-2a-restricted 
anti-VSV CTL. Goodenow et al. (7) have cloned a  single BALB/c H-2 gene (27.5)  in 
bacteriophage and transferred this along with the HSV-1 tk gene into Ltk- cells by 
the technique of DNA-mediated gene transfer. One clone derived from this transfec- 
tion, 8-5, expressed the BALB/c H-2L  'i molecule, as determined by the reaction with 
anti-H-2La-specific  monoclones.  Additional  evidence  demonstrating  that  the  new 
molecule expressed in the transformed cells was H-2L  a was provided by showing that gW 
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containing P815-VSV labeled target cells along with BALB/c anti-VSV effectors. The three panels 
represent three different experiments. Net release of isotope in the absence of inhibitor ceils in the 
experiment in the top panel is 31%; middle panel, 60%; and bottom panel, 39%. Percent inhibition 
=  [1  -  (percent net release in the presence of inhibitor cells)/(percent net release in the absence of 
inhibitor cells)] ×  100. 
the  DNA  sequence  of the  genomic  clone  (27.5)  corresponded  to  the  known  protein 
sequence  of H-2L °  (14).  Further,  the molecule  precipitated  on 8-5 cells by anti-H-2L  ° 
monoclones  is  identical  to  H-2L °  isolated  from  BALB/c  splenocytes,  as  determined 1270  FUNCTION OF  H-2L  d 
by two-dimensional  gel electrophoresis.  Thus,  these  data  demonstrate  that  8-5 cells 
express  H-2L  d but  not  other  gene  products  derived  from  the  H-2 a  haplotype  and 
therefore provide a  unique  tool for evaluating the role of this  gene in H-2-restricted 
recognition by anti-viral  CTL.  Because VSV-infected 8-5 transformants  were recog- 
nized and lysed by anti-VSV CTL generated in BALB/c animals, this unequivocally 
shows that  H-2L  a is a  restricting molecule for anti-VSV CTL. Further confirmation 
that  H-2L  d and  not an H-2k-encoded  gene product  is responsible  for this  effect was 
demonstrated  by the  use  of an  anti-H-2L  d monoclone.  When  added  to target  cells, 
this antibody blocked the ability of CTL to cause lysis. 
It has been previously shown that anti-influenza CTL are restricted by both H-2D a 
and H2L a. However, we previously demonstrated that monoclonal antibodies directed 
against  H-2D  d do  not  block  the  cytolytic activity  of anti-VSV  CTL,  ruling  out  a 
restricting role for this antigen. To further assess the ability of other H-2  a antigens to 
restrict  anti-VSV  CTL,  we  generated  effector cells  in  BALB/c animals  and  tested 
them against P815-VSV  (H-2d)-infected target cells in the presence of unlabeled 8-5- 
VSV  (H-2L d)  inhibitor cells.  Similar  to P815-VSV inhibitor cells, the 8-5-VSV cells 
also  inhibited  most of the CTL activity,  although  usually to a  slightly lesser extent 
than P815-VSV cells. We interpret  the lower inhibitory activity of the 8-5-VSV cells 
to be due to their lesser sensitivity to lysis, a  factor that correlates with the ability of 
cells  to  inhibit  in  the  competition  assay  (18),  and  not  antigen  density,  since  the 
expression of H-2L  d is actually greater on 8-5 cells than P815. Therefore, our data are 
most consistent with the postulate that H-2L  d is the only molecule expressed by H-2  d 
mice  that  restricts  anti-VSV  CTL.  However,  since  in  some  experiments  complete 
blocking of CTL  activity  was  not  seen  by  8-5-VSV  cells,  it  is  still  possible  that  a 
minor component of restricting activity is exhibited by class I gene products(s)  other 
than H-2K or -D. 
The homology between H-2K or H-2D alleles is no greater than that between H-2K 
or H-2D genes themselves  (20).  In most cases, H-2 molecules share ~75-85% of their 
sequence  (20,  21).  More recently, H-2L or L-like gene products have been described 
in several different mouse H-2 haplotypes  (22, 23). Maloy and Coligan (24)  observed 
a  94%  sequence  homology  between  H-2L  d  and  H-2D  b,  including  no  amino  acid 
differences  between  residues  158  and  338.  They  raised  the  possibility  that  H-2L d 
rather than H-2D a is allelic  to H-2D b.  However, as an alternative,  H-2L d may be a 
duplicated  H-2D b gene created  by unequal  crossing over, similar to that  postulated 
for  the  two  (duplicated)  IgG2a  genes  detected  in  mice  of the  species  Mus  musculus 
molossinus  (25).  Regardless  of the similarities  between  H-2L  d and  H-2D  b, the  former 
and not the latter serves as a restriction element for anti-VSV CTL. Thus, the variant 
residues  in the first two domains of these molecules play a  critical role in controlling 
the generation of anti-VSV CTL. 
The  technique  of DNA-mediated  gene  transfer  has  also  been  used  by Orn  et  al. 
(17)  and  Mellor  et  al.  (6),  who demonstrated  that  H-2L  d restricts  anti-lymphocytic 
choriomeningitis  virus  CTL  and  that  H-2K  b  restricts  anti-influenza  virus  CTL, 
respectively.  Thus,  this  technique  provides  a  valuable  method  for  analyzing  the 
structure and function of individual H-2 genes. 
Summary 
Mouse thymidine kinase  (tk-)  C3H L  (H-2 k) cells transformed by the technique of 
DNA-mediated gene transfer with the herpes simplex virus tk gene together with the FORMAN ET  AL.  1271 
BALB/c H-2L a gene express H-2L  d molecules indistinguishable from  their counter- 
parts  on  spleen  cells.  An  established  cloned  cell  line  (8-5)  was  used  to  assess  the 
function of the H-2L  d antigen in determining the specificity of alloreactive as well as 
anti-vesicular stomatitis virus (VSV) cytotoxic T  cells (CTL). 
Both anti-H-2  a and anti-H-2L  a CTL  displayed a  cytotoxic effect against 8-5 cells 
but  not  a  control  cell  line  transformed  with  the  tk  gene  only  (tk  +  cells).  Further 
evidence that  8-5 cells express H-2L  a was provided by the finding that  monoclonal 
anti-H-2L  a but not H-2D  a antibodies blocked target cell lysis by the effector cells. 
Both  BALB/c  (H-2 't)  and DBA/2  (H-2 d)  animals generated  anti-VSV CTL  that 
lysed infected 8-5 but  not  tk  +  ceils. To  further  establish that  H-2L  d  controlled the 
specificity of the  effector cells, a  monoclonal  antibody  directed against  H-2L  a  was 
shown to inhibit lysis of infected 8-5 target cells. 
To determine whether other H-2a-encoded gene products could serve as restricting 
antigens  for anti-VSV  CTL  in  BALB/c  animals,  unlabeled VSV  infected 8-5  cells 
were tested for their ability to block lysis of SXchromiUm-labeled P815 (H-2a)-infected 
target cells. The 8-5-VSV inhibitor cells inhibited lysis to a  slighly lesser extent than 
unlabeled P815-VSV cells, indicating that H-2L  a plays a  major if not exclusive role 
in restricting anti-VSV CTL  in H-2 a animals. 
Received  for publication 27 August  1982 and in revised  form 9 November 1982. 
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